However, a transient flare of CLD is often observed in carriers seroconverting from HBe (high HBV replication) to anti-HBe (low HBV replication) during natural infection, suggesting that therapeutic vaccination against HBx may be a viable approach to investigate. The gene discussed is HBE1; the disease is congenital secretory chloride diarrhea 1.